POLL: Which Most Recent FDA Approval Are You Excited About?

Poll

Click here to answer this week's poll.

Which Most Recent FDA Approval Are You Excited About?

Sirolimus topical gel 0.2% for facial angiofibromas with tuberous sclerosis complex
Ruxolitinib cream 1.5% for nonsegmental vitiligo
Baricitinib for alopecia areata
Roflumilast cream 0.3% for plaque psoriasis
Ustekinumab for pediatric psoriatic arthritis
Hyaluronic acid filler for loss of jawline definition
Related Content
© 2023 MJH Life Sciences

All rights reserved.